Loading...
Loading...
Among the 2 tracked institutional investors we monitor, MBRX (MOLECULIN BIOTECH INC) is held with a combined value of $52.82K across 16,035 shares. The largest holder is VANGUARD GROUP INC with a position worth $51.45K. VANGUARD GROUP INC opened a new position in the most recent quarter.
Total Institutional Value
$52.82K
Total Shares Held
16,035
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $51.45K | 0.00% | New |
| 2 | BlackRock, Inc. | $1.37K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of MBRX with a position worth $51.45K, representing 0.00% of their portfolio. In total, 2 institutional investors hold MBRX with a combined value of $52.82K.
In the most recent quarter, 1 fund opened a new position in MBRX.
Institutional investors hold $52.82K worth of MBRX stock across 2 positions. The largest institutional holder is VANGUARD GROUP INC with $51.45K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For MBRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their MBRX positions.
| 2026-08-25 |
| 9.9% | 2026-08-10 |
| 5.0% | 2026-08-06 |
SEC Schedule 13D (activist) and 13G (passive) filings for MBRX. Filed when an investor acquires 5%+ ownership.
Last Close
$6.31
2026-10-21
YTD
-91.3%
0% of 52-week range